ArticleOncotarget2016

VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer.

Wei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.